MKI67 and breast carcinoma: The use of Ki-67 (Ki) nuclear antigen as a marker for breast cancer prognosis is a relatively new study worldwide with the controversy surrounding whether it can be successfully utilized in making decisions for the treatment of Breast Cancer.